Recent Publications - drug safety

A few publications may have future date in the results which means they might be set for future issue releases.

Please wait while the information is being loaded...

Controlled Release of Molecules to Enhance Cell Survival and Regeneration.

Issue Release: 2025

Retinal Explant Culture from Mouse, Human, and Nonhuman Primates and Its Applications in Vision Research.

Issue Release: 2025

NANOSUSPENSIONS: ENHANCING DRUG BIOAVAILABILITY THROUGH NANONIZATION.

Issue Release: 2024

[Pharmacological properties and clinical development overview of pertuzumab (genetical recombination), trastuzumab (genetical recombination) and vorhyaluronidase alfa (genetical recombination) (PHESGO combination for ‍subcutaneous injection MA, IN)].

Issue Release: 2024

Innovative approaches to cardiovascular safety pharmacology assessment.

Issue Release: 2024

Characterization of two virulent Salmonella phages and transient application in egg, meat and lettuce safety.

Issue Release: 2024

Effectiveness and Drug Survival of Ixekizumab and Secukinumab in Patients with Moderate to Severe Plaque Psoriasis: Real-World Data from Bucharest, Romania.

Issue Release: 2024

Systemic oncological therapy in breast cancer patients on dialysis.

Issue Release: 2024

Chlorogenic acid/carboxymethyl chitosan nanoparticle-assisted biomultifunctional hyaluronic acid-based hydrogel scaffolds for burn skin repair.

Issue Release: 2024

[Pharmacological characteristics and clinical study results of ensitrelvir fumaric acid (XOCOVA Tablets 125 ‍mg)].

Issue Release: 2024

ONC206 targeting ClpP induces mitochondrial dysfunction and protective autophagy in hepatocellular carcinoma cells.

Issue Release: 2024

Prenatal exposure to vortioxetine and vilazodone: Impact on depressive- and anxiety-like behavioral manifestations in young rat offspring.

Issue Release: 2024

Comparative analysis of adverse events among intravesical drugs in bladder cancer: a real-world study on FAERS database.

Issue Release: 2024

Shared genetics between breast cancer and predisposing diseases identifies novel breast cancer treatment candidates.

Issue Release: 2024

Learning Molecular Representation in a Cell.

Issue Release: 2024

Evaluation of artificial intelligence-generated drug therapy communication skill competencies in medical education.

Issue Release: 2024

Real-World Clinical Performance of a Novolimus-Eluting Stent Versus a Sirolimus-Eluting Stent.

Issue Release: 2024

N-803 Plus BCG Treatment for BCG-Naïve or -Unresponsive Non-Muscle Invasive Bladder Cancer: A Plain Language Review.

Issue Release: 2024

A Long-Term Safety and Tolerability Study of TV-46000 for Subcutaneous Use in Patients with Schizophrenia: A Phase 3, Randomized, Double-Blinded Clinical Trial.

Issue Release: 2024

Pharmacotherapeutic options for metabolic dysfunction-associated steatotic liver disease: where are we today?

Issue Release: 2024

What is Geriatric Care in Pharma?

Why do Pharma Companies Use CROs?

What Are the Therapeutic Approaches to Mitigate Cellular Stress?

Why is Geriatric Care Important?

What is Patient Education in Pharma?

What are the Challenges in Implementing Collaborative Care Models?

Why is Medication Adherence Important?

What are the Key Cellular Stress Pathways?

How Can Technology Aid in Patient Education?

What is Cellular Stress?

Partnered Content Networks

Relevant Topics